IDEXX Laboratories, Inc. (IDXX) Financial Statements (2024 and earlier)

Company Profile

Business Address ONE IDEXX DRIVE
WESTBROOK, ME 04092-2041
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)
Annual | Quarterly

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11314438490124472
Cash and cash equivalents11314438490124188
Short-term investments      284
Receivables401368331269249235
Inventory, net of allowances, customer advances and progress billings368269210195173164
Inventory368269210195173164
Other current assets220174138125108101
Total current assets:1,1019561,063680654972
Noncurrent Assets
Operating lease, right-of-use asset1191059181✕✕
Property, plant and equipment649588555534437379
Intangible assets, net (including goodwill)459458296298256244
Goodwill362359243240214200
Intangible assets, net (excluding goodwill)989953584244
Other noncurrent assets418330290240190119
Total noncurrent assets:1,6451,4821,2321,153883741
TOTAL ASSETS:2,7472,4372,2951,8321,5371,713
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities544575490395330320
Accounts payable11011675727067
Accrued liabilities434459416323261253
Deferred revenue38404341✕✕
Debt757550289399655
Deferred revenue and credits✕✕✕✕✕✕29
Contract with customer, liability✕✕✕✕✕41✕
Other undisclosed current liabilities57974    
Total current liabilities:1,2367645837257701,005
Noncurrent Liabilities
Long-term debt and lease obligation694863936766601606
Long-term debt, excluding current maturities694775858699601606
Liabilities, other than long-term debt208121143163146157
Deferred revenue and credits✕✕✕✕✕✕36
Deferred revenue31414649✕✕
Contract with customer, liability✕✕✕✕✕61✕
Deferred tax liabilities, net✕✕✕✕✕ 25
Deferred income tax liabilities891233✕✕
Other liabilities687186818596
Operating lease, liability101877767✕✕
Other undisclosed noncurrent liabilities     29 
Total noncurrent liabilities:9029841,079929776763
Total liabilities:2,1381,7471,6621,6551,5471,767
Equity
Equity, attributable to parent, including:609690632177(10)(54)
Common stock111111111110
Treasury stock, value(4,392)(3,571)(2,800)(2,601)(2,289)(1,912)
Additional paid in capital1,4631,3771,2951,2141,1381,074
Accumulated other comprehensive loss(78)(53)(54)(46)(42)(36)
Retained earnings3,6002,9202,1761,5961,168804
Other undisclosed equity, attributable to parent565456
Equity, attributable to noncontrolling interest   1000
Total equity:609690633178(9)(54)
TOTAL LIABILITIES AND EQUITY:2,7472,4372,2951,8321,5371,713

Income Statement (P&L) ($ in millions)
Annual | Quarterly

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues3,3673,2152,7072,4072,2131,969
Revenue, net✕✕✕✕✕✕1,969
Cost of revenue(1,363)(1,326)(1,136)(1,041)(972)(872)
Cost of goods and services sold      (872)
Gross profit:2,0041,8891,5711,3661,2421,097
Operating expenses(1,106)(957)(877)(813)(750)(684)
Operating income:899932695553491413
Interest and debt expense(40)(30)(33)(31)(35)(37)
Other undisclosed income from continuing operations before equity method investments, income taxes   1015
Income from continuing operations before equity method investments, income taxes:859902662522458381
Other undisclosed income from continuing operations before income taxes10    
Income from continuing operations before income taxes:860903662522458381
Income tax expense(181)(158)(80)(94)(81)(118)
Income from continuing operations:679745582428377263
Income before gain (loss) on sale of properties:✕✕745582428377263
Net income:679745582428377263
Net income (loss) attributable to noncontrolling interest  0(0)(0)(0)(0)
Net income available to common stockholders, diluted:679745582428377263

Comprehensive Income ($ in millions)
Annual | Quarterly

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income:679745582428377263
Other comprehensive income (loss)(24)0(7)(4)(5)7
Comprehensive income:655745575423372270
Comprehensive income (loss), net of tax, attributable to noncontrolling interest  0(0)(0)(0)(0)
Comprehensive income, net of tax, attributable to parent:655745574423372270

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: